The PFS analysis revealed that TREM1 acted as a risk factor for patients with breast invasive carcinoma (BRCA), KIRC and LGG and a protective factor for patients with lymphoid neoplasm diffuse large B-cell lymphoma (DLBC) (Supplementary Figure 3D). The gene discussed is TREM1; the disease is lymphoid neoplasm.